Academic Journal
View in EDS

Secreted indicators of androgen receptor activity in breast cancer pre-clinical models

Bibliographic Details
Title: Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
Authors: Toru Hanamura, Jessica L. Christenson, Kathleen I. O’Neill, Emmanuel Rosas, Nicole S. Spoelstra, Michelle M. Williams, Jennifer K. Richer
Source: Breast Cancer Research, Vol 23, Iss 1, Pp 1-15 (2021)
Publisher Information: BMC, 2021.
Publication Year: 2021
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: Breast cancer, Androgen signal, Androgen receptor, Serum factor, KLK3, AZGP1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Purpose Accumulating evidence has attracted attention to the androgen receptor (AR) as a biomarker and therapeutic target in breast cancer. We hypothesized that AR activity within the tumor has clinical implications and investigated whether androgen responsive serum factors might serve as a minimally invasive indicator of tumor AR activity. Methods Based on a comprehensive gene expression analysis of an AR-positive, triple negative breast cancer patient-derived xenograft (PDX) model, 163 dihydrotestosterone (DHT)-responsive genes were defined as an androgen responsive gene set. Among them, we focused on genes that were DHT-responsive that encode secreted proteins, namely KLK3, AZGP1 and PIP, that encode the secreted factors prostate specific antigen (PSA), zinc-alpha-2-glycoprotein (ZAG) and prolactin induced protein (PIP), respectively. Using AR-positive breast cancer cell lines representing all breast cancer subtypes, expression of candidate factors was assessed in response to agonist DHT and antagonist enzalutamide. Gene set enrichment analysis (GSEA) was performed on publically available gene expression datasets from breast cancer patients to analyze the relationship between genes encoding the secreted factors and other androgen responsive gene sets in each breast cancer subtype. Results Anti-androgen treatment decreased proliferation in all cell lines tested representing various tumor subtypes. Expression of the secreted factors was regulated by AR activation in the majority of breast cancer cell lines. In GSEA, the candidate genes were positively correlated with an androgen responsive gene set across breast cancer subtypes. Conclusion KLK3, AZGP1 and PIP are AR regulated and reflect tumor AR activity. Further investigations are needed to examine the potential efficacy of these factors as serum biomarkers.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1465-542X
Relation: https://doaj.org/toc/1465-542X
DOI: 10.1186/s13058-021-01478-9
Access URL: https://doaj.org/article/0371be8231394e019312e132cfe5dbce
Accession Number: edsdoj.0371be8231394e019312e132cfe5dbce
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=1465542X&ISBN=&volume=23&issue=1&date=20211101&spage=1&pages=1-15&title=Breast Cancer Research&atitle=Secreted%20indicators%20of%20androgen%20receptor%20activity%20in%20breast%20cancer%20pre-clinical%20models&aulast=Toru%20Hanamura&id=DOI:10.1186/s13058-021-01478-9
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/0371be8231394e019312e132cfe5dbce
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.0371be8231394e019312e132cfe5dbce
RelevancyScore: 957
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 956.677795410156
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Toru+Hanamura%22">Toru Hanamura</searchLink><br /><searchLink fieldCode="AR" term="%22Jessica+L%2E+Christenson%22">Jessica L. Christenson</searchLink><br /><searchLink fieldCode="AR" term="%22Kathleen+I%2E+O%27Neill%22">Kathleen I. O’Neill</searchLink><br /><searchLink fieldCode="AR" term="%22Emmanuel+Rosas%22">Emmanuel Rosas</searchLink><br /><searchLink fieldCode="AR" term="%22Nicole+S%2E+Spoelstra%22">Nicole S. Spoelstra</searchLink><br /><searchLink fieldCode="AR" term="%22Michelle+M%2E+Williams%22">Michelle M. Williams</searchLink><br /><searchLink fieldCode="AR" term="%22Jennifer+K%2E+Richer%22">Jennifer K. Richer</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Breast Cancer Research, Vol 23, Iss 1, Pp 1-15 (2021)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: BMC, 2021.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2021
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Breast+cancer%22">Breast cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Androgen+signal%22">Androgen signal</searchLink><br /><searchLink fieldCode="DE" term="%22Androgen+receptor%22">Androgen receptor</searchLink><br /><searchLink fieldCode="DE" term="%22Serum+factor%22">Serum factor</searchLink><br /><searchLink fieldCode="DE" term="%22KLK3%22">KLK3</searchLink><br /><searchLink fieldCode="DE" term="%22AZGP1%22">AZGP1</searchLink><br /><searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Abstract Purpose Accumulating evidence has attracted attention to the androgen receptor (AR) as a biomarker and therapeutic target in breast cancer. We hypothesized that AR activity within the tumor has clinical implications and investigated whether androgen responsive serum factors might serve as a minimally invasive indicator of tumor AR activity. Methods Based on a comprehensive gene expression analysis of an AR-positive, triple negative breast cancer patient-derived xenograft (PDX) model, 163 dihydrotestosterone (DHT)-responsive genes were defined as an androgen responsive gene set. Among them, we focused on genes that were DHT-responsive that encode secreted proteins, namely KLK3, AZGP1 and PIP, that encode the secreted factors prostate specific antigen (PSA), zinc-alpha-2-glycoprotein (ZAG) and prolactin induced protein (PIP), respectively. Using AR-positive breast cancer cell lines representing all breast cancer subtypes, expression of candidate factors was assessed in response to agonist DHT and antagonist enzalutamide. Gene set enrichment analysis (GSEA) was performed on publically available gene expression datasets from breast cancer patients to analyze the relationship between genes encoding the secreted factors and other androgen responsive gene sets in each breast cancer subtype. Results Anti-androgen treatment decreased proliferation in all cell lines tested representing various tumor subtypes. Expression of the secreted factors was regulated by AR activation in the majority of breast cancer cell lines. In GSEA, the candidate genes were positively correlated with an androgen responsive gene set across breast cancer subtypes. Conclusion KLK3, AZGP1 and PIP are AR regulated and reflect tumor AR activity. Further investigations are needed to examine the potential efficacy of these factors as serum biomarkers.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1465-542X
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://doaj.org/toc/1465-542X
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.1186/s13058-021-01478-9
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/0371be8231394e019312e132cfe5dbce" linkWindow="_blank">https://doaj.org/article/0371be8231394e019312e132cfe5dbce</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.0371be8231394e019312e132cfe5dbce
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.0371be8231394e019312e132cfe5dbce
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13058-021-01478-9
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 1
    Subjects:
      – SubjectFull: Breast cancer
        Type: general
      – SubjectFull: Androgen signal
        Type: general
      – SubjectFull: Androgen receptor
        Type: general
      – SubjectFull: Serum factor
        Type: general
      – SubjectFull: KLK3
        Type: general
      – SubjectFull: AZGP1
        Type: general
      – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
        Type: general
      – SubjectFull: RC254-282
        Type: general
    Titles:
      – TitleFull: Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Toru Hanamura
      – PersonEntity:
          Name:
            NameFull: Jessica L. Christenson
      – PersonEntity:
          Name:
            NameFull: Kathleen I. O’Neill
      – PersonEntity:
          Name:
            NameFull: Emmanuel Rosas
      – PersonEntity:
          Name:
            NameFull: Nicole S. Spoelstra
      – PersonEntity:
          Name:
            NameFull: Michelle M. Williams
      – PersonEntity:
          Name:
            NameFull: Jennifer K. Richer
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-print
              Value: 1465542X
          Numbering:
            – Type: volume
              Value: 23
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast Cancer Research
              Type: main
ResultId 1